Alexandre Mebazaa, MD, PhD is Chair of the Department of Anesthesia and Critical Care at APHP, Professor of Anesthesia and Critical Care and Vice-Dean of International Affairs at Faculty of Health at Université Paris Cité and Head of the Cardiovascular Markers in Stressed Conditions research group granted by Inserm.

Alexandre Mebazaa performed his research on cardiovascular dusfunction in critical care including understanding mechanisms of hemodynamic alterations in the critically ill, benefits and side effects of vasopressors and inotropes, role of plasma biomarkers to impact patient management and recently role of AI to optimize patients outcome.

He was PI or co-PI of many trials in acute heart failure, including the very recent STRONG-HF trial that demonstrated benefits in rapid and intensive optimisation of oral GDMT of heart failure before and after discharge of an acute heart failure episode that showed marked benefits on outcome and was immediately included in the European Society of Cardiology 2023 guidelines on heart failure.

Alexandre Mebazaa published 700+ papers and was ranked "Highly Cited Researcher" the last 3 years.